13 Recruiting Schizophrenia Phase 2 Clinical Trials
Active phase 2 studies for schizophrenia enrolling across the USA. Verify eligibility and contact site coordinators.
All Schizophrenia studiesPhase 2 Studies for Schizophrenia
Study of SPG302 in Adults With Schizophrenia
📍 CenExel CNS — Garden Grove, California
View Study & Checklist ➔Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study of ANAVEX3-71 in Adults With Schizophrenia
📍 CenExel Hassman Research Institute — Marlton, New Jersey
View Study & Checklist ➔Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
📍 TG Therapeutics Investigational Trial Site — Little Rock, Arkansas
View Study & Checklist ➔A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
📍 Clinical Site — Little Rock, Arkansas
View Study & Checklist ➔A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
📍 Woodland International Research Group /ID# 275747 — Little Rock, Arkansas
View Study & Checklist ➔Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
📍 UCLA Semel Institute — Los Angeles, California
View Study & Checklist ➔Tolerability of MDMA in Schizophrenia
📍 UCLA — Los Angeles, California
View Study & Checklist ➔Study of ALTO-101 in Patients With Schizophrenia
📍 Site 5038 — Garden Grove, California
View Study & Checklist ➔A Study of Brenipatide in Adult Participants With Schizophrenia
📍 Pillar Clinical Research- Little Rock — Little Rock, Arkansas
View Study & Checklist ➔Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
📍 University of Pittsburgh — Pittsburgh, Pennsylvania
View Study & Checklist ➔Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
📍 Pillar Clinical Research LLC — Bentonville, Arkansas
View Study & Checklist ➔Acetazolamide for Treatment Resistant Schizophrenia
📍 University of Pittsburgh — Pittsburgh, Pennsylvania
View Study & Checklist ➔